Advances in the systemic treatment of head and neck cancers.
作者： Pol Specenier , Jan B Vermorken
DOI: 10.1097/CCO.0B013E3283376E15
关键词:
摘要: Purpose of reviewTo summarize the recent literature on treatment recurrent and metastatic squamous cell carcinoma head neck.Recent findingsMultiple targeted therapies novel combinations chemotherapeutic agents were tested.SummaryIn a large randomized phase III trial, add
sci-hub.se 参考文章(25)
Jill Gilbert, Anthony Cmelak, Yu Shyr, James Netterville, Brian B. Burkey, Robert J. Sinard, Wendall G. Yarbrough, Christine H. Chung, Joseph M. Aulino, Barbara A. Murphy, Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck. Cancer. ,vol. 113, pp. 186- 192 ,(2008) , 10.1002/CNCR.23545
George R. Blumenschein, Merrill S. Kies, Vassiliki A. Papadimitrakopoulou, Charles Lu, Ashok J. Kumar, Justin L. Ricker, Judy H. Chiao, Cong Chen, Stanley R. Frankel, Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza™, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer Investigational New Drugs. ,vol. 26, pp. 81- 87 ,(2008) , 10.1007/S10637-007-9075-2
T.-F. Wang, S.-C. Chu, R.-H. Kao, C.-Y. Yao, C.-C. Li, A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck. Japanese Journal of Clinical Oncology. ,vol. 38, pp. 459- 463 ,(2008) , 10.1093/JJCO/HYN052
Julius Varga, Audiometrische Darstellung der Ergebnisse bei der Behandlung der neurogenen Schwerhörigkeit mit Vitamin B1 Acta Oto-laryngologica. ,vol. 31, pp. 1- 22 ,(1943) , 10.3109/00016484309124197
Pol M. Specenier, Tudor Ciuleanu, Jane E. Latz, Luna C. Musib, Christelle L. S. Darstein, Jan B. Vermorken, Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients. Cancer Chemotherapy and Pharmacology. ,vol. 64, pp. 233- 241 ,(2009) , 10.1007/S00280-008-0853-0
Patricia A Tang, Lillian L Siu, Eric X Chen, Sebastien J Hotte, Stephen Chia, James K Schwarz, Gregory R Pond, Caitlin Johnson, A Dimitrios Colevas, Timothy W Synold, Lakshmi S Vasist, Eric Winquist, None, Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck. Investigational New Drugs. ,vol. 26, pp. 257- 264 ,(2008) , 10.1007/S10637-007-9098-8
Pol M. Specenier, Jan B. Vermorken, Current concepts for the management of head and neck cancer: chemotherapy. Oral Oncology. ,vol. 45, pp. 409- 415 ,(2009) , 10.1016/J.ORALONCOLOGY.2008.05.014
Ezra Eddy Wyssam Cohen, Anna B. Halpern, Kristen Kasza, Masha Kocherginsky, Rosalyn Williams, Everett E. Vokes, Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck. Oral Oncology. ,vol. 45, ,(2009) , 10.1016/J.ORALONCOLOGY.2009.05.637
George Fountzilas, Anna Fragkoulidi, Anna Kalogera-Fountzila, Martha Nikolaidou, Mattheos Bobos, Julien Calderaro, Felipe Andreiuolo, Marios Marselos, A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer Cancer Chemotherapy and Pharmacology. ,vol. 65, pp. 649- 660 ,(2010) , 10.1007/S00280-009-1070-1
Francesco Recchia, Giampiero Candeloro, Mario Di Staso, Stefano Necozione, Roberta Bisegna, Massimo Bratta, Vincenzo Tombolini, Silvio Rea, Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of Immunotherapy. ,vol. 31, pp. 413- 419 ,(2008) , 10.1097/CJI.0B013E31816D1D8E